Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Novo Nordisk and the Chinese group’s wholly-owned subsidiary The United Bio-Technology have entered into an exclusive license agreement for UBT251, a triple agonist of the receptors for GLP-1, GIP, ...

Thirty insulin-treated participants with diabetes who drove cars at least three times per week were enrolled and underwent two four-week periods: an alert period using CGM with active low-glucose ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ... While medications such as glucagon-like peptide 1 (GLP-1) receptor ...

It is also the first application to enable insulin delivery from a compatible Apple Watch. The algorithm technology in Tidepool Loop is intended for use with compatible integrated continuous ...

Integral feedback control strategies have proven effective in regulating ... specifically through the interplay between an additionally introduced positive autoregulation loop and the original loop, ...

Opko Health and Entera Bio have formalized their partnership as the biotechs prepare to take the first orally administered dual agonist glucagonlike-peptide 1 (GLP-1)/glucagon peptide into the clinic.